Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-25-044424
Filing Date
2025-05-15
Accepted
2025-05-15 17:26:56
Documents
53
Period of Report
2025-03-31

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT ea0241063-10q_helixacq2.htm   iXBRL 10-Q 468682
2 CERTIFICATION ea024106301ex31-1_helixacq2.htm EX-31.1 12197
3 CERTIFICATION ea024106301ex31-2_helixacq2.htm EX-31.2 12000
4 CERTIFICATION ea024106301ex32-1_helixacq2.htm EX-32.1 4611
5 CERTIFICATION ea024106301ex32-2_helixacq2.htm EX-32.2 4597
  Complete submission text file 0001213900-25-044424.txt   3584674

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE hlxb-20250331.xsd EX-101.SCH 36444
7 XBRL CALCULATION FILE hlxb-20250331_cal.xml EX-101.CAL 19567
8 XBRL DEFINITION FILE hlxb-20250331_def.xml EX-101.DEF 178227
9 XBRL LABEL FILE hlxb-20250331_lab.xml EX-101.LAB 284050
10 XBRL PRESENTATION FILE hlxb-20250331_pre.xml EX-101.PRE 182574
55 EXTRACTED XBRL INSTANCE DOCUMENT ea0241063-10q_helixacq2_htm.xml XML 299758
Mailing Address C/O CORMORANT ASSET MANAGEMENT, LP 200 CLARENDON STREET, 52ND FLOOR BOSTON MA 02116
Business Address C/O CORMORANT ASSET MANAGEMENT, LP 200 CLARENDON STREET, 52ND FLOOR BOSTON MA 02116 857 702 0377
Helix Acquisition Corp. II (Filer) CIK: 0001869105 (see all company filings)

EIN.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-41955 | Film No.: 25955986
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)